Friedreich's ataxia (FRDA) is a neurodegenerative disorder associated with cardiomyopathy and diabetes. Effective therapies for FRDA are an urgent unmet need; there are currently no options to prevent or treat this orphan disease. FRDA is caused by reduced expression of the mitochondrial protein frataxin. We have previously demonstrated that pancreatic β-cell dysfunction and death cause diabetes in FRDA. This is secondary to mitochondrial dysfunction and apoptosis but the underlying molecular mechanisms are not known. Here we show that β-cell demise in frataxin deficiency is the consequence of oxidative stress-mediated activation of the intrinsic pathway of apoptosis. The pro-apoptotic Bcl-2 family members Bad, DP5 and Bim are the key mediators of frataxin deficiency-induced β-cell death. Importantly, the intrinsic pathway of apoptosis is also activated in FRDA patients' induced pluripotent stem cell-derived neurons. Interestingly, cAMP induction normalizes mitochondrial oxidative...
Introduction
Friedreich's ataxia (FRDA) is an autosomal recessive neurodegenerative disease caused by a GAA trinucleotide repeat expansion in the first intron of the FXN gene, encoding the mitochondrial protein frataxin (1) . This expansion interferes with frataxin transcription by heterochromatin silencing (1, 2) . FRDA patients have 5-35% of normal frataxin levels, and this is the cause of the clinical and pathophysiological features of the disease (3) . FRDA is characterized by progressive gait ataxia, muscle weakness, dysarthria, and sensory loss (4) . In addition to the neurological phenotype, FRDA patients have high prevalence of hypertrophic cardiomyopathy (4, 5) , glucose intolerance and diabetes (6, 7) .
The main neuropathological features are loss of large proprioceptive primary sensory neurons in the dorsal root ganglia, atrophy of the posterior columns and the spinocerebellar tracts in the spinal cord, severe neuronal loss in the dentate nucleus in the cerebellum, and distal axonal loss in the pyramidal tracts, with variable involvement of visual and auditory pathways (8, 9) . We have recently demonstrated that pancreatic β-cell dysfunction and loss are central for diabetes development in FRDA patients (10, 11) .
Frataxin is a component of the multiprotein complex that assembles iron-sulfur (Fe-S) clusters in mitochondria, where it allosterically activates the sulfur donor enzyme NSF1 and modulates iron entry in the complex. Frataxin deficiency results in decreased Fe-S biogenesis and loss of activity of Fe-S enzymes, including several subunits of complexes I, II and III of the respiratory chain, whose impairment leads to energy deficit and enhanced production of reactive oxygen species (ROS). Frataxindeficient cells accumulate iron, mostly in mitochondria, likely as a consequence of a homeostatic mechanism trying to restore Fe-S cluster synthesis. Excess mitochondrial iron reacts with ROS and generates toxic radicals causing oxidative damage (12) (13) (14) (15) .
Cells from FRDA patients and cells rendered frataxin-deficient by RNA interference show mitochondrial dysfunction and enhanced susceptibility to ROS (16) . Frataxin silencing in neuron-like cells, obtained by differentiating neuroblastoma cells, induced accumulation of ROS and apoptosis (17) . We have shown that frataxin silencing in pancreatic β-cells induces mitochondrial dysfunction and apoptosis under basal condition and following metabolic or endoplasmic reticulum (ER) stress (10) .
Interestingly, cAMP induction by incretin analogs was protective in frataxin-deficient β-cells (10, 11) .
In eukaryotic cells, apoptosis can be executed via two molecular pathways: the extrinsic and the intrinsic pathway of apoptosis (18) . The latter, also called mitochondrial pathway of apoptosis, is activated in response to ER stress, DNA damage, and mitochondrial dysfunction. The propensity of cells to undergo apoptosis, known as the apostat, is determined by the balance and interactions between pro-and anti-apoptotic proteins of the Bcl-2 family (19) (20) (21) . The pro-apoptotic Bcl-2 proteins are divided into BH3-only sensitizers and activators. Sensitizers are activated transcriptionally (e.g. DP5, Bik and Noxa) or by dephosphorylation (e.g. Bad) and directly bind pro-survival family members (e.g. Bcl-X L , Bcl-2 and Bcl-2A1) causing the release of the activators (e.g. Bim, Puma and tBid). When freed in the cytoplasm the activators bind and activate pro-death binding partners such as Bax and Bak through a conformational change, leading to their translocation to the mitochondria, outer mitochondrial membrane permeabilization, cytochrome c release, activation of the initiator caspase-9 and the effector caspase-3 and execution of cell death. The usage of Bcl-2 proteins following different pro-apoptotic stimuli is context-dependent (19) .
The apoptosis pathway and mediators activated by frataxin deficiency in FRDA are unknown. The aim of this study was to elucidate the molecular mechanisms of apoptosis in cell models relevant to this severe disease. Since FRDA is caused by partial frataxin deficiency (absolute deficiency being lethal), RNA interference technology allows for mechanistic studies in in vitro cell models (11) . More recently, induced pluripotent stem cells (iPSCs), derived from FRDA patient fibroblasts, have been differentiated into neurons and cardiomyocytes (22) (23) (24) (25) . The FRDA patients' iPSC-derived neurons recapitulate the genetic basis of the disease, the decreased frataxin expression and the mitochondrial defects (25) . Using these two models we presently demonstrate that cell death in FRDA is mediated by enhanced mitochondrial oxidative stress and activation of the intrinsic pathway of apoptosis. The pro- We have previously demonstrated that frataxin deficiency induces mitochondrial dysfunction and sensitizes β-cells to free fatty acid (FFA)-and ER stress-induced apoptosis (10) . In other cell types frataxin deficiency enhances oxidative stress (1, 3, 26, 27) . To determine if this is also a characteristic of frataxin-deficient β-cells, we knocked down frataxin in clonal rat INS-1E β-cells (Fig. 1 ) using one of our previously validated siRNAs (10) . Frataxin silencing induced β-cell death (Fig. 1A-C) and enhanced the expression of mitochondrial superoxide dismutase (SOD2, Fig. 1D ).
This enzyme catalyzes the dismutation of superoxide radicals to H 2 O 2 and oxygen. We therefore examined whether mitochondrial H 2 O 2 production is increased, using the specific fluorescent H 2 O 2 sensor HyPer. Oxidation of HyPer, selectively targeted to the mitochondria (HyPerMito, Fig. 1E ), was significantly increased in frataxindeficient β-cells in control condition and after treatment with the FFA oleate or the ER stressor brefeldin (Fig. 1E ). In contrast, cytosolic H 2 O 2 formation, monitored by HyPerCyto oxidation, was not modified by frataxin deficiency (Fig. 1F ). H 2 O 2 is converted into the highly reactive hydroxyl radical (OH  ) in the presence of ferrous iron via the Fenton reaction (28). Using the fluorescent dye HPF, enhanced OH  formation was detected in frataxin-deficient β-cells (Fig.1G) . We also examined whether frataxin silencing modifies the thiol/disulfide mitochondrial redox equilibrium, by targeting the redox sensitive biosensor roGFP to the mitochondria (mt-roGFP1). This biosensor, which is much less pH-sensitive than HyPerMito (29), reports the mitochondrial glutathione (GSH) redox state, reflecting the cellular capacity to reduce oxidized protein-thiols via the thiol based redox couple GSH/GSSG (30). In line with our observation of enhanced mitochondrial ROS production in frataxin deficiency, frataxin silencing increased mitochondrial GSH oxidation (Fig. 1H) . In summary, frataxin deficiency induces mitochondrial oxidative stress and apoptosis in β-cells.
Oxidative stress contributes to apoptosis in frataxin-deficient β-cells.
We next used chemical and genetic approaches to examine whether increased oxidative stress mediates β-cell death. Apoptosis induced by frataxin silencing was partially prevented by the cell-permeable SOD/catalase mimetic MnTMPyP (31-33) and the superoxide anion scavenger Tiron (34) in control condition and after oleate ( Fig. 2A, F ) or brefeldin treatment (Fig. 2D) . These results were confirmed by Western blot for cleaved caspase-3 ( Fig. 2Β-C) . MnTMPyP also protected frataxindeficient rat islet cells from oleate-induced apoptosis ( (Fig. 2G) . Thus, mitochondrial oxidative stress is a key mechanism for β-cell apoptosis in FRDA.
Frataxin-deficiency activates the intrinsic pathway of apoptosis in β-cells.
Mitochondrial cytochrome c release is a hallmark of activation of the intrinsic pathway of apoptosis. Frataxin silencing induced cytochrome c release in control condition and after oleate treatment (Fig. 3A-B) . Treatment with the ROS scavenger MnTMPyP prevented cytochrome c release (Fig. 4) , showing that oxidative stress contributes to the activation of the intrinsic pathway of apoptosis under frataxin deficiency. We next examined the pro-and anti-apoptotic proteins of the Bcl-2 family controlling this apoptosis pathway (20, 21, 35, 36) . Frataxin silencing in β-cells induced the mRNA expression of the pro-apoptotic BH3-only sensitizer DP5, as well as the BH3-only activators Bim and Puma (Fig. 3C) . At the protein level, frataxin deficiency induced the Bim isoforms Bim L and Bim S , the latter being the most proapoptotic Bim splice variant (37) ( Fig. S3 ). Bad knockdown reduced β-cell apoptosis in control condition and after oleate or brefeldin exposure (Fig. 5A-B) . DP5 silencing prevented oleate-but not brefeldin-induced apoptosis ( Fig. 5D-E) , while Bim knockdown was protective against both ( Fig. 5G-H) . Bad, DP5 and Bim silencing also prevented oleate-induced apoptosis in frataxin-deficient primary rat β-cells (Fig.   5C, F, I ). Puma knockdown was not protective for frataxin-deficient β-cells (Fig. 5J-K ). The results were confirmed by Western blots for the effector caspase-3, that was significantly less activated following Bad, DP5 and Bim silencing but not after Puma knockdown (Supplementary Material, Fig. S4 ).
The intrinsic pathway of apoptosis is activated in iPSC-derived neurons from FRDA patients.
To evaluate if frataxin deficiency in neurons also leads to activation of the intrinsic pathway of apoptosis we differentiated fibroblast-derived iPSCs from two FRDA patients and one age-matched healthy individual into neurons. Since heterogeneous responses between clones have been reported (25) , two clones were examined per individual. As described by Hick and co-workers (25) , fibroblasts from FRDA patients (FA1 and FA2) had expanded GAA repeats (800/600 and 900/400, respectively), whereas the control fibroblasts (CT) had normal GAA repeats (<20).
The number of repeats was unstable during reprogramming, but stabilized in iPSC clones and during differentiation. Both FRDA iPSCs clones retained pathological GAA repeat expansions, ranging between 400 and 1000 triplets, with frataxin levels reduced at all stages to 20-30% of that of control cells (25) . The neuronal phenotype of iPSC-derived neurons was confirmed by morphology, expression of specific neuronal markers such as β-III-tubulin and microtubule-associated protein 2 (MAP2), and their ability to generate sodium currents, action potentials and calcium transients (25) . FRDA iPSC-derived neurons were shown to have impaired mitochondrial membrane potential and delayed functional maturation (25) . We confirmed that differentiated neurons from both FRDA patients showed significantly reduced frataxin protein levels as compared to control cells ( Fig. 6A and E). These FRDA neurons showed significantly enhanced cleavage of the initiator caspase-9 and the effector caspase-3 ( Fig. 6A-C) , demonstrating that the intrinsic pathway of apoptosis is activated. In keeping with the observations in β-cells, Bim L and Bim S expression was increased (Fig. 6D ). In one of the four patient clones (FA 1A) caspase activation and Bim induction were not observed, in keeping with reported inter-clonal variation (25) . Taken together, these results point to activation of the intrinsic pathway of apoptosis in neurons through Bim induction as occurs in β-cells. 7I ) and when pooling all samples (Fig. 7J) .
Expression of Bim L and Bim S was significantly reduced by forskolin in an individual clone ( Fig. 7K ) and in the pooled samples (Fig. 7L ). These data suggest that cAMP inducers also prevent the activation of the intrinsic pathway of apoptosis in neurons from FRDA patients.
Discussion
FRDA is a neurodegenerative disease caused by decreased frataxin expression. The main cell types affected by frataxin deficiency are neurons from the dorsal root ganglia and dentate nucleus of the cerebellum, cardiomyocytes and pancreatic β-cells (3, 10, 38) . Frataxin deficiency leads to β-cell dysfunction and death (10) . Reduced mitochondrial membrane potential, decreased ATP production and insulin secretion contribute to the functional β-cell defect (10) . Here, we show that frataxin deficiency in β-cells induces mitochondrial oxidative stress and activates the intrinsic pathway of apoptosis. Similar to observations in other cellular models of FRDA using RNA interference or frataxin knockout mouse cells (17, 39, 40) , frataxin silencing in β-cells enhanced mitochondrial SOD2 expression, mitochondrial hydrogen peroxide production, hydroxyl radical formation and increased mitochondrial GSH oxidation (Fig. 1) . This is probably the consequence of respiratory chain dysfunction.
Respiratory chain complexes I, II, and III need Fe-S clusters as cofactors for proper function. Reduced Fe-S cluster formation, as a consequence of frataxin deficiency, leads to impaired electron flow and premature electron leakage from the respiratory chain. These electrons react with molecular oxygen to form superoxide, which will in turn generate hydrogen peroxide via SOD2. In the presence of iron, hydrogen peroxide is transformed in the highly toxic hydroxyl radical via the Fenton reaction (41), leading to cell damage and death. Our data demonstrate that oxidative stress causes β-cell demise since chemical and genetic approaches to scavenge ROS protect frataxin-deficient cells from apoptosis (Fig. 2) . Cell death in frataxin deficiency occurs through the intrinsic pathway of apoptosis (Fig. 3) , and could be prevented by ROS scavenging (Fig. 4) . The pro-apoptotic Bcl-2 family members Bad, DP5 and
Bim are the key mediators of the intrinsic pathway of apoptosis ( Importantly, we demonstrate here that the intrinsic pathway of apoptosis is also activated in iPSC-derived neurons from FRDA patients and thus identify a common mechanism of cell death in two key cell types in FRDA ( were purified from the dispersed rat islets by autofluorescence-activated cell sorting (FACSAria; BD Bioscience) and cultured as described (56). Human islets from nondiabetic organ donors (n=5, age 53±3 years, BMI 26±2 kg/m 2 ) were isolated by collagenase digestion and density gradient purification (57) in Pisa, Italy. The islets were cultured, dispersed and transfected as previously described (58). The mean percentage of β-cells of the human islet preparations was 53±6%, as determined by insulin immunofluorescence (59). For neuronal differentiation, iPSCs from two FRDA patients and one age-matched unrelated control individual were treated for 14 days with 500 ng/ml of Noggin (60) . To allow the formation of neurospheres, the cells were then cultured in NBN media (neurobasal media A+B27+N2) supplemented with FGF-2 and EGF (both 20 ng/ml; Peprotech, UK). Neuronal precursors were maintained and propagated as neurospheres as previously described (25) . For neuronal differentiation, neurospheres were plated on laminin-coated glass coverslips in NBN media (without proliferating factors) containing brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) (100 ng/ml; Peprotech). Medium was replaced every 2-3 days. These cells have been characterized in detail by Hick et al (25) . Differentiated neurons were collected after 2, 5 or 7 weeks differentiation.
Cell treatment and apoptosis assays.
INS-1E cells were exposed to 0.5 mM oleate in RPMI 1640 medium containing 1% fetal bovine serum (FBS) and 0.75% FFA-free bovine serum albumin (BSA) (10).
Primary β-cells and dispersed rat and human islet cells were exposed to 0. 
Estimation of hydroxyl radical formation.
Hydroxyl radical formation was estimated using the fluorescent dye 3'-(phydroxyphenyl) fluorescein (HPF) (Life Technologies) according to the manufacturer's instructions.
Mitochondrial glutathione redox state measurement.
The mitochondrial glutathione redox state was analyzed using the redox-sensitive fluorescent probe roGFP1 targeted to the mitochondria (mt-roGFP1). INS-1E cells were plated in glass coverslips and transfected with control or frataxin siRNA. 16h
after transfection the cells were treated or not for 24h with 20 μM forskolin, and then they were infected with an adenovirus encoding mt-roGFP1 under the control of the cytomegalovirus promoter (multiplicity of infection 25-50). After infection the cells were further cultured for 48h in the presence or absence of 20 μM forskolin. After culture, the coverslips were mounted at the bottom of a 37°C temperature-controlled chamber placed on the stage of an inverted microscope equipped with a 40x objective.
Cells were perifused with bicarbonate-buffered Krebs solution containing 10 mM glucose at a flow rate of 1 ml/min. Cell fluorescence ratio (λ exitation 400/480 nm / λ emission 535 nm) was measured every 30s. After 20 min of perifusion, the cells were perifused with 10 M dithiothreitol (DTT) to maximally reduce roGFP1 (set to 0%), followed by 100 μM aldrithiol to maximally oxidize it (set to 100%). The fluorescence ratio was expressed in percentage of the maximally reduced and the maximally oxidized forms of roGFP1 (normalized fluorescence ratio).
Catalase activity measurement.

Frataxin was knocked down by siRNA (see below) in control INS-1E cells or INS-1E
cells stably overexpressing catalase inside the mitochondria. Catalase enzyme activity was measured by ultraviolet spectroscopy in control and catalase overexpressing cell lysates. The decomposition of H 2 O 2 was monitored at 240 nm as previously described (65) . One unit of catalase activity was defined as 1 μM of H 2 O 2 per minute at 25°C. mRNA was isolated from INS-1E cells, primary rat β-cells and dispersed rat islet cells using the Dynabeads mRNA DIRECT kit (Invitrogen) and reverse transcribed as previously described (63, 71) . Real-time PCR was performed using Rotor-Gene SyBR
RNA interference.
INS-1E cells, FACS-purified primary rat
Green on a Rotor-Gene Q cycler (Qiagen) (72), or using Q SYBR Green Supermix (BIO-RAD) on a MyiQ2 instrument Single Color (BIO-RAD) (59, 63). Gene expression was calculated as copies/ml using the standard curve approach (73) . 
Statistical analysis.
Data are shown as means ± SE. Non-normally distributed variables were log- 
